Overview of the CSIRO Australian Animal Health Laboratory.
Emerging infectious diseases arising from livestock and wildlife pose serious threats to global human health, as shown by a series of continuous outbreaks involving highly pathogenic influenza, SARS, Ebola and MERS. The risk of pandemics and bioterrorism threats is ever present and growing, but our ability to combat them is limited by the lack of available vaccines, therapeutics and rapid diagnostics. The use of high bio-containment facilities, such as the CSIRO Australian Animal Health Laboratory, plays a key role studying these dangerous pathogens and facilitates the development of countermeasures. To combat diseases like MERS, we must take a holistic approach that involves the development of early biomarkers of infection, a suite of treatment options (vaccines, anti-viral drugs and antibody therapeutics) and appropriate animal models to test the safety and efficacy of candidate treatments.
Emerging Infectious Diseases Program, CSIRO Health and Biosecurity, Australia. Electronic address: john.lowenthal@csiro.au.
John
J
Lowenthal
D000818:Animals; D001315:Australia; D035843:Biomedical Research / Q000379:methods*; D021821:Communicable Diseases, Emerging / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D003264:Containment of Biohazards; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D006801:Humans; D007753:Laboratories; D015047:Zoonoses / Q000209:etiology* / Q000628:therapy*
Emerging infectious diseases; High-biocontainment; MERS